Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer

被引:0
作者
Meliha Mehmeti
Roni Allaoui
Caroline Bergenfelz
Lao H. Saal
Stephen P. Ethier
Martin E. Johansson
Karin Jirström
Karin Leandersson
机构
[1] Lund University,Center for Molecular Pathology, Department of Translational Medicine
[2] Lund University,Division of Oncology and Pathology, Department of Clinical Sciences
[3] Medical University of South Carolina,Department of Pathology and Laboratory Medicine, Hollings Cancer Center
来源
Breast Cancer Research | / 17卷
关键词
Breast Cancer; Estrogen Receptor; Breast Cancer Cell; TLR4 Expression; TLR4 Protein Expression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Estrogen receptor β- an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?
    Maehle, Bjorn O.
    Collett, Karin
    Tretli, Steinar
    Akslen, Lars A.
    Grotmol, Tom
    [J]. APMIS, 2009, 117 (09) : 644 - 650
  • [42] Prognostic significance of Claudin 12 in estrogen receptor-negative breast cancer
    Iravani, Omid
    Yip, George Wai-Cheong
    Thike, Aye Aye
    Chua, Pei Jou
    Scully, Olivia Jane
    Tan, Puay-Hoon
    Bay, Boon-Huat
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (10) : 878 - 883
  • [43] Oral Contraceptive Use and Estrogen/Progesterone Receptor-Negative Breast Cancer among African American Women
    Rosenberg, Lynn
    Boggs, Deborah A.
    Wise, Lauren A.
    Adams-Campbell, Lucile L.
    Palmer, Julie R.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (08) : 2073 - 2079
  • [44] Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
    He Dou
    Fucheng Li
    Youyu Wang
    Xingyan Chen
    Pingyang Yu
    Siyuan Jia
    Yuling Ba
    Danli Luo
    Tian Gao
    Zhaoting Li
    Min Xiao
    [J]. Diagnostic Pathology, 19
  • [45] Estrogen receptor-negative/progesterone receptor-positive breast cancer has distinct characteristics and pathologic complete response rate after neoadjuvant chemotherapy
    Dou, He
    Li, Fucheng
    Wang, Youyu
    Chen, Xingyan
    Yu, Pingyang
    Jia, Siyuan
    Ba, Yuling
    Luo, Danli
    Gao, Tian
    Li, Zhaoting
    Xiao, Min
    [J]. DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
  • [46] Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast Cancer
    Liu, Xi-Yu
    Ma, Ding
    Xu, Xiao-En
    Jin, Xi
    Yu, Ke-Da
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    [J]. THERANOSTICS, 2018, 8 (22): : 6386 - 6399
  • [47] Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases
    Nass, Norbert
    Ignatov, Atanas
    Andreas, Ludwig
    Weissenborn, Christine
    Kalinski, Thomas
    Sel, Saadettin
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 2017, 147 (05) : 625 - 634
  • [48] Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases
    Norbert Nass
    Atanas Ignatov
    Ludwig Andreas
    Christine Weißenborn
    Thomas Kalinski
    Saadettin Sel
    [J]. Histochemistry and Cell Biology, 2017, 147 : 625 - 634
  • [49] Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer
    Kalinina, Tatiana
    Kononchuk, Vladislav
    Alekseenok, Efim
    Obukhova, Darya
    Sidorov, Sergey
    Strunkin, Dmitry
    Gulyaeva, Lyudmila
    [J]. GENES, 2021, 12 (04)
  • [50] Estrogen receptor-positive and estrogen receptor-negative human breast cancer cells: Regulation of expression of cancer-related genes by estradiol and tamoxifen
    Yuan, Xia
    Liu, Guojin
    Murthy, Ven
    [J]. CURRENT SIGNAL TRANSDUCTION THERAPY, 2008, 3 (01) : 7 - 21